Better Therapeutics Inc. (BTTX)
0.00
-0.00 (-100.00%)
At close: Feb 28, 2025, 2:38 PM
No 1D chart data available
Bid | n/a |
Market Cap | 10.9K |
Revenue (ttm) | n/a |
Net Income (ttm) | -92.01M |
EPS (ttm) | -1.1 |
PE Ratio (ttm) | n/a |
Forward PE | n/a |
Analyst | n/a |
Ask | n/a |
Volume | 1,010 |
Avg. Volume (20D) | 26,912 |
Open | 0.00 |
Previous Close | 0.00 |
Day's Range | 0.00 - 0.00 |
52-Week Range | 0.00 - 0.22 |
Beta | 1.69 |
About BTTX
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also in...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 17, 2021
Employees 54
Stock Exchange NASDAQ
Ticker Symbol BTTX
Website https://www.bettertx.com